Janus Henderson discloses 6.2% stake in Avadel Pharmaceuticals
PositiveFinancial Markets

Janus Henderson has announced a 6.2% stake in Avadel Pharmaceuticals, signaling confidence in the company's potential for growth. This investment is significant as it reflects Janus Henderson's strategic approach to identifying promising opportunities in the pharmaceutical sector, which could lead to increased innovation and advancements in healthcare.
— Curated by the World Pulse Now AI Editorial System






